Clinical and Anamnestic Characteristics, Cardiovascular Pharmacotherapy and Long-term Outcomes in Multimorbid Patients after COVID-19

Clinical and Anamnestic Characteristics, Cardiovascular Pharmacotherapy and Long-term Outcomes in Multimorbid Patients after COVID-19

Aim. To study the clinical and anamnestic characteristics, pharmacotherapy of cardiovascular diseases (CVD) and long-term outcomes in post-COVID-19 patients with cardiovascular multimorbidity (CVMM), enrolled in the prospective hospital registry.Material and methods. In patients with confirmed COVID...

Full description

Saved in:
Bibliographic Details
Main Authors: A. A. Smirnov, M. M. Loukianov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. A. Maltseva, E. N. Belova, V. G. Klyashtorniy, E. V. Kudryashov, O. E. Karpov, O. M. Drapkina
Format: Article
Language:English
Published: Столичная издательская компания 2022-11-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
new coronavirus infection
prospective follow-up
cardiovascular diseases
cardiovascular multimorbidity
long-term outcomes
pharmacotherapy
registry
Online Access:https://www.rpcardio.online/jour/article/view/2816
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.rpcardio.online/jour/article/view/2816

Similar Items